Holding(s) in Company
TR-1: Standard form fornotification of major holdings
LONDON, 20 October 2026 –Hikma Pharmaceuticals PLC (LEI:549300BNS685UXH4JI75)
(LSE: HIK) (NasdaqDubai: HIK) announcesas follows:
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”) | |
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii |
|
Full chain of controlled undertakings through which the voting rights and/or the | X |
| |
Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
Wellington Management Group LLP (Chain 1) | Wellington Group Holdings LLP | 4.970000 | 5.020000% | |
Wellington Management Group LLP (Chain 1) | Wellington Investment Advisors Holdings LLP | 4.970000 | 5.020000% | |
Wellington Management Group LLP (Chain 1) | Wellington Management Global Holdings, Ltd. | |||
Wellington Management Group LLP (Chain 1) | Wellington Management Europe GmbH | |||
Wellington Management Group LLP (Chain 2) | Wellington Group Holdings LLP | 4.970000 | 5.020000% | |
Wellington Management Group LLP (Chain 2) | Wellington Investment Advisors Holdings LLP | 4.970000 | 5.020000% | |
Wellington Management Group LLP (Chain 2) | Wellington Management Company LLP |
Place of completion | London, UK |
Date of completion |
20-Oct-2026
|